What is Abbott's R&D?

Abbott (ABT) reported R&D of $767M in Q1 2026.

How has Abbott's R&D changed year-over-year?

Abbott's R&D increased by 7.1% year-over-year, from $716M to $767M.

What is the long-term trend for Abbott's R&D?

Over 4 years (2021 to 2025), Abbott's R&D has grown at a 1.8% compound annual growth rate (CAGR), from $2.74B to $2.94B.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Abbott ABT R&D

R&D at other companies

Becton, Dickinson and CompanyBDX

$249M+7.3%

Bio-Rad LaboratoriesBIO

$62.9M-14.4%

HaemoneticsHAE

$14.45M-21.1%

Merit Medical SystemsMMSI

$22.61M+0.6%

DexComDXCM

$145.3M+0.1%

Edwards LifesciencesEW

$263.3M+3.4%

Segments

By segment

See full

Medical Devices$444M+10.7%

Diagnostic Products$155M+2.6%

Nutritional Products$54M+3.8%

Established Pharmaceuticals$41M-2.4%

Other financials

Income statement

See full

Revenue$11.2B+7.8%

Gross profit$6.3B+6.5%

Operating income$1.3B-20.6%

Net income$1.1B-18.7%

EPS (diluted)$0.61-19.7%

Balance sheet

See full

Cash & equivalents$6.8B+4.1%

Total debt$34.0B+157%

Total equity$52.1B+6.7%

Total assets$110.43B+35.6%

Cash flow

See full

Operating cash flow$1.3B-7.2%

CapEx$399.0M-17.6%

Free cash flow$916.0M-1.8%

Valuation

See full

Market cap$163.94B-31.8%

Enterprise value$191.18B-22.5%

P/E26.1×+8.9×

P/S3.6×-1.9×

Profitability

See full

Gross margin56.3%+0.4pp

Operating margin17.1%+0.2pp

Net margin13.9%-18.0pp

FCF margin16.3%+0.6pp

Returns & leverage

See full

Return on equity12.4%-18.4pp

Debt / equity0.7×+0.4×

Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Abbott’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Abbott's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Abbott's R&D?: Abbott (ABT) reported R&D of $767M in Q1 2026.
How has Abbott's R&D changed year-over-year?: Abbott's R&D increased by 7.1% year-over-year, from $716M to $767M.
What is the long-term trend for Abbott's R&D?: Over 4 years (2021 to 2025), Abbott's R&D has grown at a 1.8% compound annual growth rate (CAGR), from $2.74B to $2.94B.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.